Skip to main content

and
  1. Article

    Open Access

    Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial

    Variation in de-adoption of ineffective or unsafe treatments is not well-understood. We examined de-adoption of erythropoiesis-stimulating agents (ESA) in anemia treatment among patients with chronic kidney di...

    Khoa Vu, Jiani Zhou, Alexander Everhart, Nihar Desai, Jeph Herrin in BMC Nephrology (2021)